Oral Gabapentin pre-op

PreclinicalSmall molecule

Oral Gabapentin pre-op is one of 3 small molecule programs targeting After Cardiac Surgery. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

After Cardiac SurgeryUnknown status

After Cardiac SurgeryPreclinical

Unknown status

Competition

Competitive Landscape

3 competitors in After Cardiac Surgery

#DrugCompanyPhaseTrials

Pituitrin

QQianfoshan Hospital

Preclinical

1 2

Dexmedetomidine /ml

SSt. Justine's Hospital

Preclinical

1 3

Oral Gabapentin pre-op

JJames Cook University Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

After Cardiac Surgery1 trial

Enhanced Recovery After Cardiac Surgery

Unknown status·JJames Cook University Hospital·N/A·NCT03859102·80 enrolled

Breast Cancer Surgery1 trial

Comparison of Mean Analgesia Consumption for Postoperative Pain With Single Dose of Preoperative Oral Gabapentin Versus Placebo in Patients Undergoing Breast Cancer Surgery

Completed·SShaukat Khanum Memorial Cancer Hospital & Research Centre·Preclinical·NCT07804784·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Oral Gabapentin pre-op. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Oral Gabapentin pre-op compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Oral Gabapentin pre-op. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — James Cook University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: JJames Cook University Hospital

Oral Gabapentin pre-op

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

After Cardiac Surgery1 trial

Breast Cancer Surgery1 trial

References

Drug Info

Quick Facts

Related News